The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis
Abstract
BACKGROUND: Rheumatoid arthritis (RA), a chronic, progressive inflammatory, autoimmune disease, can substantially reduce health-related quality of life (HRQoL) and lead to severe disability and early mortality. Patient-reported outcome (PRO) instruments are used to assess the patient experience of RA symptoms and impacts, and can capture RA treatment effects. To address limitations in existing PRO instruments, this research aimed to establish the content validity of a new instrument, the Rheumatoid Arthritis Symptom Questionnaire (RASQ), to assess the signs and symptoms of RA. METHOD: The most important and relevant sign and symptom concepts for RA patients were identified through a targeted review of the published literature, expert opinion, and concept elicitation patient interviews. Cognitive interviews were conducted with patients to test the comprehensibility and comprehensiveness of the RASQ. RESULTS: Seven symptoms emerged consistently across the conceptual research: joint pain, joint swelling, joint stiffness, joint tenderness, joint warmth, muscle pain, and tiredness. Draft item content was developed to assess these symptoms, in addition to a single impact item, resulting in three RASQ versions: two utilizing a 7 day recall period (one assessing symptoms at their worst, the other on average) and a third using a 24 hour recall period assessing symptoms at their worst. Cognitive interview results demonstrated patient understanding and ability to use the instrument. CONCLUSIONS: Content validity of the RASQ was established in accordance with instrument development guidelines. The RASQ fills a measurement gap by assessing the RA signs and symptoms most important to patients. Research evaluating the RASQ's psychometric properties is underway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, the gold-standard methods to measure the impact of RA on daily life rely on infrequent clinical visits that may often occur every 3–4 months, with assessments depending on a combination of subjective clinician-determined scores2 and patient-reported outcomes3.”
From Digital health technologies and machine learning augment patient reported outcomes to remotely characterise rheumatoid arthritis (2024) · cites this paper as [2]
Citations
Cites
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27584 · Cited by 9,619
Crossing the Quality Chasm: A New Health System for the 21st Century
Committee on Quality of Health Care in America (2002) · Journal For Healthcare Quality · doi:10.1111/j.1945-1474.2002.tb00463.x · Cited by 8,483
Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., & Erikson, P. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.04054.x · Cited by 5,521
Ericsson (1993) · doi:10.1037/0033-295x.87.3.215 · Cited by 4,539
Research synthesis: the practice of cognitive interviewing
Beatty, P. C., & Willis, G. B. (2007) · Public Opinion Quarterly · doi:10.1093/poq/nfm006 · Cited by 1,615
The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
Cross, M., Smith, E., Hoy, D., Carmona, L., Wolfe, F., Vos, T., Williams, B., Gabriel, S., Lassere, M., Johns, N., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204627 · Cited by 1,153
Patrick, D. L., Burke, L. B., Gwaltney, C. J., Leidy, N. K., Martin, M. L., Molsen, E., & Ring, L. (2011) · Value in Health · doi:10.1016/j.jval.2011.06.013 · Cited by 1,135
van der Heijde, D. M., van 't Hof, M. A., van Riel, P. L., Theunisse, L. A., Lubberts, E. W., van Leeuwen, M. A., van Rijswijk, M. H., & van de Putte, L. B. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.11.916 · Cited by 1,087
Development of a disease activity score based on judgment in clinical practice by rheumatologists.
van der Heijde, D. M. F. M., Hof, M. V. '., van Riel, P. L., & van de Putte, L. B. (1993) · PubMed · Cited by 787
Health assessment questionnaire (HAQ)
(2009) · Dictionary of Rheumatology · doi:10.1007/978-3-211-79280-3_429 · Cited by 693
Research works printed but not linked: 10
- Gibofsky A., 2012, Am J Manag Care, 18, 295
- Centers for Disease Control and Prevention, 2013, Morb Mortal Wkly Rep, 62, 869
- Centers for Disease Control and Prevention, 2005, Morb Mortal Wkly Rep, 58, 421
- Finney A, 2010, Nurs Times, 106, 22
- US Department of Health and Human Services, Food and Drug Administration, 2009, Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims
- Bruce B, 2005, Clin Exp Rheumatol, 23, S14
- Salaffi F, 2010, Clin Exp Rheumatol, 28, 186
- Leeb BF, 2008, J Rheumatol, 35, 1294
- van der Heijde DM, 1993, J Rheumatol, 20, 579
- Rindfleisch JA, 2005, Am Fam Physician, 72, 1037
Cited by
Crouthamel, M., Quattrocchi, E., Watts, S., Wang, S., Berry, P., Garcia-Gancedo, L., Hamy, V., & Williams, R. E. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.9656 · Cited by 76
“RA is a chronic, progressive autoimmune disease affecting the mobile joints of the body, which may result in substantial and irreversible disability; symptoms include joint pain or tenderness, joint swelling, morning stiffness, reduction in joint range of movement (ROM), muscle pain, and fatigue [9,13].”
BackgroundCreagh, A. P., Hamy, V., Yuan, H., Mertes, G., Tomlinson, R., Chen, W.-H., Williams, R., Llop, C., Yee, C., Duh, M. S., et al. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01013-y · Cited by 64
Creagh, A. P., Hamy, V., Yuan, H., Mertes, G., Tomlinson, R., Chen, W.-H., Williams, R., Llop, C., Yee, C., Duh, M. S., et al. (2022) · doi:10.1101/2022.11.18.22282305 · Cited by 64
Peasgood, T., Caruana, J. M., & Mukuria, C. (2023) · Patient · doi:10.1007/s40271-022-00611-w · Cited by 50
“, from Monday to Sunday) [65], or the 5-day working week [66].”
BackgroundKempton, C. L., Trask, P. C., Parnes, A. D., Niggli, M., Campinha‐Bacote, A., Callaghan, M. U., O'Connell, N. M., Paz‐Priel, I., & Mahlangu, J. N. (2021) · Haemophilia · doi:10.1111/hae.14222 · Cited by 25
Metadata
- Authors
- Banderas, B., Skup, M., Shields, A. L., Mazar, I., & Ganguli, A.
- Affiliations
- Adelphi Values, Boston, MA, USA;
- AbbVie (United States) (US)
- Corresponding author
- Banderas, Benjamin
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa UK Limited
- Published
- 2017-06-22
- Volume
- 33
- Issue
- 9
- Pages
- 1643-1651
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W2620717087
- Cited by
- 10
- References
- 29
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2021: 2 · 2018: 2 · 2017: 1
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Medical Research and Opinion (publishedVersion)
- PubMed (publishedVersion)
- Funders
- AbbVie Inc
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Nursing › Research and Theory › Health Education and Validation
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- rheumatoid arthritis, patient-reported outcome measures, symptom assessment, content validity, cognitive interviewing, joint pain, joint swelling, joint stiffness, myalgia, fatigue, symptom impact, health-related quality of life
- MeSH terms
- Patient Reported Outcome Measures, Adult, Aged, Arthritis, Rheumatoid, Female, Humans, Male, Middle Aged, Psychometrics, Quality of Life, Surveys and Questionnaires
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis. https://app.cochat.ai/papers/10.1080/03007995.2017.1338562
- The paper
- Banderas, B., Skup, M., Shields, A. L., Mazar, I., & Ganguli, A. (2017). Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis. Current Medical Research and Opinion. https://doi.org/10.1080/03007995.2017.1338562
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.